Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis

FASEB Journal

Volumn 18, Issue 2, 2004, Pages 300-310

  Kuwano, Takashi ^a   Nakao, Shintaro ^a   Yamamoto, Hidetaka ^a   Tsuneyoshi, Masazumi ^a   Yamamoto, Tomoya ^a   Kuwano, Michihiko ^b   Ono, Mayumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KURUME UNIVERSITY   (Japan)

Author keywords

COX2; Inflammatory disease; Prastanoid; Vascular endothelial growth factor

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 3 (3 FLUOROPHENYL) 4 [4 (METHYLSULFONYL)PHENYL] 5,5 DIMETHYL 5H FURAN 2 ONE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; FURANONE DERIVATIVE; INTERLEUKIN 1BETA; ONO 8809; ONO AE1 259; ONO AE1 329; ONO AE3 208; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E4 RECEPTOR ANTAGONIST; PROSTAGLANDIN F2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; PROSTANOID; PROTEIN TYROSINE KINASE INHIBITOR; SEMAXANIB; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; THROMBOXANE A2 RECEPTOR STIMULATING AGENT; TILMACOXIB; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; DRUG EFFECT; DRUG EFFICACY; DRUG STRUCTURE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; CELL MOVEMENT; CELLS, CULTURED; CORNEA; CYCLOOXYGENASE 2; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; ISOENZYMES; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RECEPTORS, PROSTAGLANDIN E; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA;

EID: 0442277878     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.03-0473com     Document Type: Article

References (53)

1. Williams, C. S., and DuBois, R. N. (1996) Prostaglandin endoperoxide synthase: why two isoforms? Am. J. Physiol. 270, G393-G400
2. Arslan, A., and Zingg, H. H. (1996) Regulation of COX-2 gene expression in rat uterus in vivo and in vitro. Prostaglandins 52, 463-481
3. Tanaka, Y., Takahashi, M., Kawaguchi, M., and Amano, F. (1997) Delayed release of prostaglandins from arachidonic acid and kinetic changes in prostaglandin H synthase activity on the induction of prostaglandin H synthase-2 after lipopolysaccharide-treatment of RAW264.7 macrophage-like cells. Biol. Pharm. Bull. 20, 322-326
4. Sheng, H., Shao, J., Washington, M. K., and DuBois, R. N. (2001) Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J. Biol. Chem. 276, 18075-18081
5. Ben-Av, P., Crofford, L. J., Wilder, R. L., and Hla, T. (1995) Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett. 372, 83-87
6. Tsuji, S., Kawano, S., Tsujii, M., Michida, T., Masuda, E., Gunawan, E. S., and Hori, M. (1998) Mucosal microcirculation and angiogenesis in gastrointestinal tract. Nippon Rinsho 56, 2247-2252
7. Sheng, H., Shao, J., Morrow, J. D., Beauchamp, R. D., and DuBois, R. N. (1998) Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res. 58, 362-366
8. Kakiuchi, Y., Tsuji, S., Tsujii, M., Murata, H., Kawai, N., Yasumaru, M., Kimura, A., Komori, M., Irie, T., Miyoshi, E., et al. (2002) Cyclooxygenase-2 activity altered the cell-surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis. Cancer Res. 62, 1567-1572
9. Tsuji, S., Tsujii, M., Kawano, S., and Hori, M. (2001) Cyclooxygenase-2 upregulation as a perigenetic change in carcinogenesis. J. Exp. Clin. Cancer Res. 20, 117-129
10. Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., and Hla, T. (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55, 3785-3789
11. Murata, H., Kawano, S., Tsuji, S., Tsuji, M., Sawaoka, H., Kimura, Y., Shiozaki, H., and Hori, M. (1999) Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am. J. Gastroenterol. 94, 451-455
12. Xue, Y. W., Zhang, Q. F., Zhu, Z. B., Wang, Q., and Fu, S. B. (2003) Expression of cyclooxygenase-2 and clinicopathologic features in human gastric adenocarcinoma. World J. Gastroenterol. 9, 250-253
13. Achiwa, H., Yatabe, Y., Hida, T., Kuroishi, T., Kozaki, K., Nakamura, S., Ogawa, M., Sugiura, T., Mitsudomi, T., and Takahashi, T. (1999) Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. Clin. Cancer Res. 5, 1001-1005
14. Richards, R. G., and Almond, G. W. (1994) Lipopolysaccharide-induced increases in porcine serum cortisol and progesterone concentrations are not mediated solely by prostaglandin F2 alpha. Inflammation 18, 203-214
15. Davis, B. J., Lennard, D. E., Lee, C. A., Tiano, H. F., Morham, S. G., Wetsel, W. C., and Langenbach, R. (1999) Anovulation in cyclooxygenase-2-deficient mice is restored by prostaglandin E2 and interleukin-1beta. Endocrinology 140, 2685-2695
16. Caivano, M., and Cohen, P. (2000) Role of mitogen-activated protein kinase cascades in mediating lipopolysaccharide-stimulated induction of cyclooxygenase-2 and IL-1 beta in RAW264 macrophages. J. Immunol. 164, 3018-3025
17. Kirtikara, K., Raghow, R., Laulederkind, S. J., Goorha, S., Kanekura, T., and Ballou, L. R. (2000) Transcriptional regulation of cyclooxygenase-2 in the human microvascular endothelial cell line, HMEC-1: control by the combinatorial actions of AP2, NF-IL-6 and CRE elements. Mol. Cell. Biochem. 203, 41-51
18. Bamba, H., Ota, S., Kato, A., Adachi, A., Itoyama, S., and Matsuzaki, F. (1999) High expression of cyclooxygenase-2 in macrophages of human colonic adenoma. Int. J. Cancer 83, 470-475
19. Fiebich, B. L., Mueksch, B., Boehringer, M., and Hull, M. (2000) Interleukin-1beta induces cyclooxygenase-2 and prostaglandin E(2) synthesis in human neuroblastoma cells: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB. J. Neurochem. 75, 2020-2028
20. Wadleigh, D. J., and Herschman, H. R. (1999) Transcriptional regulation of the cyclooxygenase-2 gene by diverse ligands in murine osteoblasts. Biochem. Biophys. Res. Commun. 264, 865-870
21. Crofford, L. J., Tan, B., McCarthy, C. J., and Hla, T. (1997) Involvement of nuclear factor kappa B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes. Arthritis Rheum. 40, 226-236
22. Inoue, H., Yokoyama, C., Hara, S., Tone, Y., and Tanabe, T. (1995) Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. J. Biol. Chem. 270, 24965-24971
23. Yoshida, S., Ono, M., Shono, T., Izumi, H., Ishibashi, T., Suzuki, H., and Kuwano, M. (1997) Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol. Cell. Biol. 17, 4015-4023
24. Torisu, H., Ono, M., Kiryu, H., Furue, M., Ohmoto, Y., Nakayama, J., Nishioka, Y., Sone, S., and Kuwano, M. (2000) Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha. Int. J. Cancer 85, 182-188
25. Ono, M., Torisu, H., Fukushi, J., Nishie, A., and Kuwano, M. (1999) Biological implications of macrophage infiltration in human tumor angiogenesis. Cancer Chemother. Pharmacol. 43, S69-S71
26. Kawai, S. (1998) Drug delivery system of anti-inflammatory and anti-rheumatic drugs. Nippon Rinsho 56, 782-787
27. Dequeker, J., Hawkey, C., Kahan, A., Steinbruck, K., Alegre, C., Baumelou, E., Begaud, B., Isomaki, H., Littlejohn, G., and Mau, J. (1998) Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis. Br. J. Rheumatol. 37, 946-951
28. Reddy, B. S., and Rao, C. V. (2000) Colon cancer: a role for cyclo-oxygenase-2-specific nonsteroidal anti-inflammatory drugs. Drugs Aging 16, 329-334
29. Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., and Offerhaus, G.J. (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med. 328, 1313-1316
30. Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., and Taketo, M. M. (1996) Suppression of intestinal polyposis in Apc delta-716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87, 803-809
31. Oshima, M., Murai, N., Kargman, S., Arguello, M., Luk, P., Kwong, E., Taketo, M. M., and Evans, J. F. (2001) Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res. 61, 1733-1740
32. Sawaoka, H., Tsuji, S., Tsujii, M., Gunawan, E. S., Sasaki, Y., Kawano, S., and Hori, M. (1999) Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab. Invest. 79, 1469-1477
33. Masferrer, J. L., Koki, A., and Seibert, K. (1999) COX-2 inhibitors. A new class of antiangiogenic agents. Ann. N.Y. Acad. Sci. 889, 84-86
34. Riendeau, D., Percival, M. D., Boyce, S., Brideau, C., Charleson, S., Cromlish, W., Ethier, D., Evans, J., Falgueyret, J. P., Ford-Hutchinson, A. W., et al. (1997) Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br. J. Pharmacol. 121, 105-117
35. Wakitani, K., Nanayama, T., Masaki, M., and Matsushita, M. (1998) Profile of JTE-522 as a human cyclooxygenase-2 inhibitor. Jpn. J. Pharmacol. 78, 365-371
36. Hirata, A., Ogawa, S., Kometani, T., Kuwano, T., Naito, S., Kuwano, M., and Ono, M. (2002) ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase. Cancer Res. 62, 2554-2560
37. Nakao, S., Kuwano, T., Ishibashi, T., Kuwano, M., and Ono, M. (2003) Synergistic effect of TNF-α in soluble VCAM-1-induced angiogenesis through α4 integrins. J. Immunol. 170, 5704-5711
38. Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennette, J. C., Mahler, J. F., Kluckman, K. D., Ledford, A., Lee, C. A., et al. (1995) Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83, 473-482
39. Ogawa, S., Yoshida, S., Ono, M., Onoue, H., Ito, Y., Ishibashi, T., Inomata, H., and Kuwano, M. (1999) Induction of macrophage inflammatory protein-1α and vascular endothelial growth factor during inflammatory neovascularization in the mouse cornea. Angiogenesis 3, 327-334
40. Itokawa, T., Nokihara, H., Nishioka, Y., Sone, S., Iwamoto, Y., Yamada, Y., McMahon, G., Shibuya, M., Kuwano, M., Ono, M., et al. (2002) Antiangiogenic effect by SU5416 is partly attributable to inhibition of FIt-1 receptor signaling. Mol. Cancer Ther. 1, 295-302
41. Voronov, E., Shouval, D. S., Krelin, Y., Cagnano, E., Benharroch, D., Iwakura, Y., Dinarello, C. A., and Apte, R. N. (2003) IL-1 is required for tumor invasiveness and angiogenesis. Proc. Natl. Acad. Sci. USA 100, 2645-2650
42. Yano, S., Nokihara, H., Goto, H., Ogawa, H., Kanematsu, T., Miki, T., Uehara, H., Saijo, Y., Nukiwa, T., Sone, S., et al. (2003) Multifunctional interlieukin-1β promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion-, invasion- and angiogenesis-related molecules. Cancer Sci. 94, 244-252
43. Saijo, Y., Tanaka, M., Miki, M., Suzuki, T., Maemondo, M., Hong, X., Tazawa, R., Kikuchi, T., Matsushima, K., Nukiwa, T., et al. (2002) Proinflammatory cytokine IL-1β promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction. J. Immunol. 169, 469-475
44. Salven, P., Hattori, K., Heissig, B., and Rafii, S. (2002) Interleukin-1α promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion. FASEB J. 16, 1471-1473
45. Majima, M., Hayashi, I., Muramatsu, M., Katada, J., Yamashina, S., and Katori, M. (2000) Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br. J. Pharmacol. 130, 641-649
46. Cheng, T., Cao, W., Wen, R., Steinberg, R. H., and LaVail, M. M. (1998) Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Muller cells. Invest. Ophthalmol. Vis. Sci. 39, 581-591
47. Graeber, J. E., Glaser, B. M., Setty, B. N., Jerdan, J. A., Walenga, R. W., and Stuart, M.J. (1990) 15-Hydroxyeicosatetraenoic acid stimulates migration of human retinal microvessel endothelium in vitro and neovascularization in vivo. Prostaglandins 39, 665-673
48. He, H., Venema, V. J., Gu, X., Venema, R. C., Marrero, M. B., and Caldwell, R. B. (1999) Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J. Biol. Chem. 274, 25130-25135
49. Daniel, T. O., Liu, H., Morrow, J. D., Crews, B. C., and Marnett, L.J. (1999) Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res. 59, 4574-4577
50. Coussens, L. M., and Werb, Z. (2002) Inflammation and cancer (review). Nature (London) 420, 860-867
51. Bol, D. K., Rowley, R. B., Ho, C. P., Pilz, B., Dell, J., Swerdel, M., Kiguchi, K., Muga, S., Klein, R., and Fischer, S. M. (2002) Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development. Cancer Res. 62, 2516-2521
52. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med. 324, 1-8
53. Zhang, X., Morham, S. G., Langenbach, R., and Young, D. A. (1999) Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts. J. Exp. Med. 190, 451-459